Aristotle University Of Thessaloniki (AUTH)
Η διαγνωστική και προγνωστική αξία των μεταβολών του επιγενετικού προτύπου μεθυλίωσης στο νεφροκυτταρικό καρκίνο
Abstract
dc:descriptionPurpose: DNA methylation makes up a main part of the molecular mechanism of cancer evolution and has shown promising results in the diagnosis and prognosis of renal cell cancer (RCC). In this study, we investigated the possible presence of characteristic epigenetic alterations in cancerous tissue and the association of promoter methylation of PCDH17, NEFH, RASSF1A and FHIT genes with the prognosis of non-metastatic renal cell cancer (RCC) patients. Material and methods: Cancerous and normal adjacent tissues from surgical specimens of 41 patients with long follow-up were treated for DNA isolation and bisulfite conversion. The gene promoter methylation was determined with quantitative Methylation Specific PCR (qMSP) and the respective relative quantities were calculated with ACTB as the reference gene. Wilcoxon signed-rank test was used for paired methylation comparisons, while univariate linear regression and Mann-Whitney test were applied for associating methylation status with clinical and disease characteristics. Cox regression proportional hazards models and Kaplan-Meier plots were used for survival analyses in reference to methylation status. Results: Paired comparisons showed tissue-specific hypermethylation for PCDH17 (P<0.001), NEFH (P<0.001), RASSF1A (P=0.032), while a positive association of methylation in normal tissues with age was demonstrated for PCDH17 (P<0.001), RASSF1A (P<0.001), FHIT (P<0.001). PCDH17 was more methylated in cases with clear cell RCC (P=0.015) and high-grade tumor (P=0.013), while NEFH methylation was higher in locally advanced cases (P=0.032). PCDH17 hypermethylation in cancerous and normal tissues was linked to shorter disease-specific survival (DSS, P=0.026, P=0.004), disease-free survival (DFS, P=0.004, P=0.019) while NEFH hypermethylation in cancerous tissues was related to shorter DSS (P=0.032). Increased methylation difference of NEFH was also associated with shorter DSS (P=0.041) and DFS (P=0.020), while the corresponding parameter for PCDH17 was associated with poor DFS (P=0.014) Kaplan- Meier curves for hypermethylation in cancer tissues demonstrated different clinical courses for PCDH17 (P=0.017), NEFH (P=0.023) regarding DSS, and PCDH17 (P=0.001) regarding DFS.Conclusion: Our study not only highlights the diagnostic perspective of the methylation status of the above genes and the prognostic value of PCDH17, NEFH methylation in cancer tissues but also is the first report of the prognostic value of methylation status in normal tissues and the range of methylation alterations between the comparing tissue categories, which can contribute to improved assessment of recurrence risk.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koudonas, Antonios
- Κουδώνας, Αντώνιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52635